Select Medical (SEM) to Release Earnings on Thursday

Select Medical (NYSE:SEM - Get Free Report) is expected to release its Q1 2025 earnings data after the market closes on Thursday, May 1st. Analysts expect Select Medical to post earnings of $0.45 per share and revenue of $1.40 billion for the quarter. Select Medical has set its FY 2025 guidance at 1.090-1.190 EPS.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. On average, analysts expect Select Medical to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Select Medical Stock Up 1.8 %

NYSE:SEM traded up $0.33 during mid-day trading on Tuesday, reaching $18.45. The stock had a trading volume of 1,176,292 shares, compared to its average volume of 832,906. The company has a market capitalization of $2.38 billion, a price-to-earnings ratio of 11.18, a price-to-earnings-growth ratio of 0.64 and a beta of 1.38. Select Medical has a 1-year low of $14.99 and a 1-year high of $40.98. The stock's 50 day simple moving average is $17.00 and its two-hundred day simple moving average is $22.10. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Monday, March 3rd were paid a $0.0625 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a yield of 1.36%. Select Medical's dividend payout ratio (DPR) is 15.15%.

Insider Activity

In other news, CEO David S. Chernow sold 225,000 shares of Select Medical stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the sale, the chief executive officer now owns 714,516 shares of the company's stock, valued at approximately $12,861,288. The trade was a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 11.60% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. UBS Group decreased their target price on Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a research note on Friday, January 3rd. StockNews.com upgraded Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. Royal Bank of Canada decreased their target price on Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a research note on Monday, February 24th. Benchmark upgraded Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price for the company in a research note on Monday, February 24th. Finally, Mizuho assumed coverage on Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 target price for the company. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $26.80.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.